{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:50:48Z","timestamp":1793469048502,"version":"4.5.0"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s12035-023-03563-w","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T13:02:24Z","timestamp":1692277344000},"page":"132-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression"],"prefix":"10.1007","volume":"61","author":[{"given":"Yutong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0205-6342","authenticated-orcid":false,"given":"Xingshun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"8","key":"3563_CR1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/ijs.12357","volume":"9","author":"ML Hackett","year":"2014","unstructured":"Hackett ML, Pickles K (2014) Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 9(8):1017\u20131025. https:\/\/doi.org\/10.1111\/ijs.12357","journal-title":"Int J Stroke"},{"issue":"5","key":"3563_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00415-006-0058-6","volume":"253","author":"S Paolucci","year":"2006","unstructured":"Paolucci S, Gandolfo C, Provinciali L, Torta R, Toso V (2006) The Italian multicenter observational study on post-stroke depression (DESTRO). J Neurol 253(5):556\u2013562. https:\/\/doi.org\/10.1007\/s00415-006-0058-6","journal-title":"J Neurol"},{"issue":"3","key":"3563_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1055\/s-0041-1731958","volume":"12","author":"GS Sharma","year":"2021","unstructured":"Sharma GS, Gupta A, Khanna M, Prakash NB (2021) Post-stroke depression and its effect on functional outcomes during inpatient rehabilitation. J Neurosci Rural Pract 12(3):543\u2013549. https:\/\/doi.org\/10.1055\/s-0041-1731958","journal-title":"J Neurosci Rural Pract"},{"issue":"6","key":"3563_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1176\/appi.psy.50.6.563","volume":"50","author":"B Poynter","year":"2009","unstructured":"Poynter B, Shuman M, Diaz-Granados N, Kapral M, Grace SL, Stewart DE (2009) Sex differences in the prevalence of post-stroke depression: a systematic review. Psychosomatics 50(6):563\u2013569. https:\/\/doi.org\/10.1176\/appi.psy.50.6.563","journal-title":"Psychosomatics"},{"key":"3563_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainresbull.2020.12.012","volume":"168","author":"A Sarkar","year":"2021","unstructured":"Sarkar A, Sarmah D, Datta A, Kaur H, Jagtap P, Raut S, Shah B, Singh U, et al (2021) Post-stroke depression: chaos to exposition. Brain Res Bull 168:74\u201388. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.12.012","journal-title":"Brain Res Bull"},{"issue":"3","key":"3563_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00415-021-10597-4","volume":"269","author":"J Guo","year":"2022","unstructured":"Guo J, Wang J, Sun W, Liu X (2022) The advances of post-stroke depression: 2021 update. J Neurol 269(3):1236\u20131249. https:\/\/doi.org\/10.1007\/s00415-021-10597-4","journal-title":"J Neurol"},{"issue":"11","key":"3563_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/s1474-4422(19)30078-x","volume":"18","author":"K Shi","year":"2019","unstructured":"Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD (2019) Global brain inflammation in stroke. Lancet Neurol 18(11):1058\u20131066. https:\/\/doi.org\/10.1016\/s1474-4422(19)30078-x","journal-title":"Lancet Neurol"},{"issue":"12","key":"3563_CR8","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jagp.2017.07.012","volume":"25","author":"JM Kim","year":"2017","unstructured":"Kim JM, Kang HJ, Kim JW, Bae KY, Kim SW, Kim JT, Park MS, Cho KH (2017) Associations of tumor necrosis factor-\u03b1 and interleukin-1\u03b2 levels and polymorphisms with post-stroke depression. Am J Geriatr Psychiatry 25(12):1300\u20131308. https:\/\/doi.org\/10.1016\/j.jagp.2017.07.012","journal-title":"Am J Geriatr Psychiatry"},{"issue":"8","key":"3563_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/10749357.2020.1755813","volume":"27","author":"Y Chen","year":"2020","unstructured":"Chen Y, Pu J, Liu Y, Tian L, Chen X, Gui S, Xu S, Song X, et al (2020) Pro-inflammatory cytokines are associated with the development of post-stroke depression in the acute stage of stroke: a meta-analysis. Top Stroke Rehabil 27(8):620\u2013629. https:\/\/doi.org\/10.1080\/10749357.2020.1755813","journal-title":"Top Stroke Rehabil"},{"issue":"4","key":"3563_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1179\/016164110x12656393665080","volume":"32","author":"L Yang","year":"2010","unstructured":"Yang L, Zhang Z, Sun D, Xu Z, Zhang X, Li L (2010) The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurol Res 32(4):340\u2013346. https:\/\/doi.org\/10.1179\/016164110x12656393665080","journal-title":"Neurol Res"},{"issue":"1","key":"3563_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.genhosppsych.2011.09.020","volume":"34","author":"JA Su","year":"2012","unstructured":"Su JA, Chou SY, Tsai CS, Hung TH (2012) Cytokine changes in the pathophysiology of poststroke depression. Gen Hosp Psychiatry 34(1):35\u201339. https:\/\/doi.org\/10.1016\/j.genhosppsych.2011.09.020","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"3563_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12883-017-0980-5","volume":"17","author":"G Meng","year":"2017","unstructured":"Meng G, Ma X, Li L, Tan Y, Liu X, Liu X, Zhao Y (2017) Predictors of early-onset post-ischemic stroke depression: a cross-sectional study. BMC Neurol 17(1):199. https:\/\/doi.org\/10.1186\/s12883-017-0980-5","journal-title":"BMC Neurol"},{"issue":"12","key":"3563_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/cns.13732","volume":"27","author":"Z Li","year":"2021","unstructured":"Li Z, Xu H, Xu Y, Lu G, Peng Q, Chen J, Bi R, Li J, et al (2021) Morinda officinalis oligosaccharides alleviate depressive-like behaviors in post-stroke rats via suppressing NLRP3 inflammasome to inhibit hippocampal inflammation. CNS Neurosci Ther 27(12):1570\u20131586. https:\/\/doi.org\/10.1111\/cns.13732","journal-title":"CNS Neurosci Ther"},{"key":"3563_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2147\/ndt.S291164","volume":"17","author":"X Yi","year":"2021","unstructured":"Yi X, Zhu X, Zhou Y, Zhang D, Li M, Zhu Y, Guo X (2021) The combination of insulin resistance and serum interleukin-1\u03b2 correlates with post-stroke depression in patients with acute ischemic stroke. Neuropsychiatr Dis Treat 17:735\u2013746. https:\/\/doi.org\/10.2147\/ndt.S291164","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3563_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.psyneuen.2016.07.001","volume":"72","author":"HJ Kang","year":"2016","unstructured":"Kang HJ, Bae KY, Kim SW, Kim JT, Park MS, Cho KH, Kim JM (2016) Effects of interleukin-6, interleukin-18, and statin use, evaluated at acute stroke, on post-stroke depression during 1-year follow-up. Psychoneuroendocrinology 72:156\u2013160. https:\/\/doi.org\/10.1016\/j.psyneuen.2016.07.001","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"3563_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41398-021-01359-x","volume":"11","author":"M Korostynski","year":"2021","unstructured":"Korostynski M, Hoinkis D, Piechota M, Golda S, Pera J, Slowik A, Dziedzic T (2021) Toll-like receptor 4-mediated cytokine synthesis and post-stroke depressive symptoms. Transl Psychiatry 11(1):246. https:\/\/doi.org\/10.1038\/s41398-021-01359-x","journal-title":"Transl Psychiatry"},{"key":"3563_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jad.2021.06.037","volume":"293","author":"CH Chi","year":"2021","unstructured":"Chi CH, Huang YY, Ye SZ, Shao MM, Jiang MX, Yang MY, Wu Q, Shao B, et al (2021) Interleukin-10 level is associated with post-stroke depression in acute ischaemic stroke patients. J Affect Disord 293:254\u2013260. https:\/\/doi.org\/10.1016\/j.jad.2021.06.037","journal-title":"J Affect Disord"},{"issue":"8","key":"3563_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/15622975.2011.588247","volume":"13","author":"JM Kim","year":"2012","unstructured":"Kim JM, Stewart R, Kim SW, Shin IS, Kim JT, Park MS, Park SW, Kim YH, et al (2012) Associations of cytokine gene polymorphisms with post-stroke depression. World J Biol Psychiatry 13(8):579\u2013587. https:\/\/doi.org\/10.3109\/15622975.2011.588247","journal-title":"World J Biol Psychiatry"},{"key":"3563_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.bbi.2020.04.004","volume":"88","author":"D Wu","year":"2020","unstructured":"Wu D, Zhang G, Zhao C, Yang Y, Miao Z, Xu X (2020) Interleukin-18 from neurons and microglia mediates depressive behaviors in mice with post-stroke depression. Brain Behav Immun 88:411\u2013420. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.004","journal-title":"Brain Behav Immun"},{"issue":"3","key":"3563_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/156720209788970036","volume":"6","author":"P Boss\u00f9","year":"2009","unstructured":"Boss\u00f9 P, Salani F, Cacciari C, Picchetto L, Cao M, Bizzoni F, Rasura M, Caltagirone C, et al (2009) Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res 6(3):163\u2013170. https:\/\/doi.org\/10.2174\/156720209788970036","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"3563_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.1999.79.1.1","volume":"79","author":"AV Turnbull","year":"1999","unstructured":"Turnbull AV, Rivier CL (1999) Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79(1):1\u201371. https:\/\/doi.org\/10.1152\/physrev.1999.79.1.1","journal-title":"Physiol Rev"},{"issue":"2","key":"3563_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1586\/14737175.2014.877841","volume":"14","author":"N El Husseini","year":"2014","unstructured":"El Husseini N, Laskowitz DT (2014) The role of neuroendocrine pathways in prognosis after stroke. Expert Rev Neurother 14(2):217\u2013232. https:\/\/doi.org\/10.1586\/14737175.2014.877841","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"3563_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0301-0082(98)00034-3","volume":"56","author":"G Stoll","year":"1998","unstructured":"Stoll G, Jander S, Schroeter M (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56(2):149\u2013171. https:\/\/doi.org\/10.1016\/s0301-0082(98)00034-3","journal-title":"Prog Neurobiol"},{"issue":"3","key":"3563_CR24","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3892\/etm.2020.8933","volume":"20","author":"EE Nagy","year":"2020","unstructured":"Nagy EE, Frigy A, Sz\u00e1sz JA, Horv\u00e1th E (2020) Neuroinflammation and microglia\/macrophage phenotype modulate the molecular background of post-stroke depression: a literature review. Exp Ther Med 20(3):2510\u20132523. https:\/\/doi.org\/10.3892\/etm.2020.8933","journal-title":"Exp Ther Med"},{"issue":"1","key":"3563_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41398-020-01008-9","volume":"10","author":"A Zahrai","year":"2020","unstructured":"Zahrai A, Vahid-Ansari F, Daigle M, Albert PR (2020) Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression. Transl Psychiatry 10(1):334. https:\/\/doi.org\/10.1038\/s41398-020-01008-9","journal-title":"Transl Psychiatry"},{"issue":"9","key":"3563_CR26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1177\/0004867413488220","volume":"47","author":"K Makhija","year":"2013","unstructured":"Makhija K, Karunakaran S (2013) The role of inflammatory cytokines on the aetiopathogenesis of depression. Aust N Z J Psychiatry 47(9):828\u2013839. https:\/\/doi.org\/10.1177\/0004867413488220","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"3563_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12888-022-03805-6","volume":"22","author":"X Qiu","year":"2022","unstructured":"Qiu X, Wang H, Lan Y, Miao J, Pan C, Sun W, Li G, Wang Y, et al (2022) Blood biomarkers of post-stroke depression after minor stroke at three months in males and females. BMC Psychiatry 22(1):162. https:\/\/doi.org\/10.1186\/s12888-022-03805-6","journal-title":"BMC Psychiatry"},{"issue":"10","key":"3563_CR28","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.29271\/jcpsp.2021.10.1224","volume":"31","author":"Y Kang","year":"2021","unstructured":"Kang Y, Yang Y, Wang J, Ma Y, Cheng H, Wan D (2021) Correlation between intestinal flora and serum inflammatory factors in post-stroke depression in ischemic stroke. J Coll Physicians Surg Pak 31(10):1224\u20131227. https:\/\/doi.org\/10.29271\/jcpsp.2021.10.1224","journal-title":"J Coll Physicians Surg Pak"},{"key":"3563_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fpsyt.2019.00030","volume":"10","author":"H Himmerich","year":"2019","unstructured":"Himmerich H, Patsalos O, Lichtblau N, Ibrahim MAA, Dalton B (2019) Cytokine research in depression: principles, challenges, and open questions. Front Psychiatry 10:30. https:\/\/doi.org\/10.3389\/fpsyt.2019.00030","journal-title":"Front Psychiatry"},{"key":"3563_CR30","doi-asserted-by":"publisher","unstructured":"Wijeratne T, Sales C (2021) Understanding why post-stroke depression may be the norm rather than the exception: the anatomical and neuroinflammatory correlates of post-stroke depression. J Clin Med 10(8). https:\/\/doi.org\/10.3390\/jcm10081674","DOI":"10.3390\/jcm10081674"},{"issue":"12","key":"3563_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen GY, Nu\u00f1ez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10(12):826\u2013837. https:\/\/doi.org\/10.1038\/nri2873","journal-title":"Nat Rev Immunol"},{"key":"3563_CR32","doi-asserted-by":"publisher","first-page":"175628641877425","DOI":"10.1177\/1756286418774254","volume":"11","author":"E G\u00fclke","year":"2018","unstructured":"G\u00fclke E, Gelderblom M, Magnus T (2018) Danger signals in stroke and their role on microglia activation after ischemia. Ther Adv Neurol Disord 11:1756286418774254. https:\/\/doi.org\/10.1177\/1756286418774254","journal-title":"Ther Adv Neurol Disord"},{"issue":"8","key":"3563_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/s1474-4422(16)00114-9","volume":"15","author":"\u00c1 Chamorro","year":"2016","unstructured":"Chamorro \u00c1, Dirnagl U, Urra X, Planas AM (2016) Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol 15(8):869\u2013881. https:\/\/doi.org\/10.1016\/s1474-4422(16)00114-9","journal-title":"Lancet Neurol"},{"issue":"1","key":"3563_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","volume":"249","author":"D Tang","year":"2012","unstructured":"Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT (2012) PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249(1):158\u2013175. https:\/\/doi.org\/10.1111\/j.1600-065X.2012.01146.x","journal-title":"Immunol Rev"},{"issue":"2","key":"3563_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.14336\/ad.2018.0324","volume":"10","author":"HY Chung","year":"2019","unstructured":"Chung HY, Kim DH, Lee EK, Chung KW, Chung S, Lee B, Seo AY, Chung JH, et al (2019) Redefining chronic inflammation in aging and age-related diseases: proposal of the senoinflammation concept. Aging Dis 10(2):367\u2013382. https:\/\/doi.org\/10.14336\/ad.2018.0324","journal-title":"Aging Dis"},{"key":"3563_CR36","doi-asserted-by":"publisher","unstructured":"Richard SA, Sackey M, Su Z, Xu H (2017) Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke. Biosci Rep 37(6).\nhttps:\/\/doi.org\/10.1042\/bsr20171104","DOI":"10.1042\/bsr20171104"},{"issue":"7","key":"3563_CR37","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17(7):796\u2013808. https:\/\/doi.org\/10.1038\/nm.2399","journal-title":"Nat Med"},{"key":"3563_CR38","doi-asserted-by":"publisher","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023-. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","DOI":"10.1038\/sigtrans.2017.23"},{"key":"3563_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/cia.S233909","volume":"15","author":"H Pawluk","year":"2020","unstructured":"Pawluk H, Wo\u017aniak A, Grze\u015bk G, Ko\u0142odziejska R, Kozakiewicz M, Kopkowska E, Grzechowiak E, Kozera G (2020) The role of selected pro-inflammatory cytokines in pathogenesis of ischemic stroke. Clin Interv Aging 15:469\u2013484. https:\/\/doi.org\/10.2147\/cia.S233909","journal-title":"Clin Interv Aging"},{"key":"3563_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98. https:\/\/doi.org\/10.1186\/1742-2094-11-98","journal-title":"J Neuroinflammation"},{"key":"3563_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fneur.2017.00467","volume":"8","author":"A Mizuma","year":"2017","unstructured":"Mizuma A, Yenari MA (2017) Anti-inflammatory targets for the treatment of reperfusion injury in stroke. Front Neurol 8:467. https:\/\/doi.org\/10.3389\/fneur.2017.00467","journal-title":"Front Neurol"},{"key":"3563_CR42","doi-asserted-by":"publisher","unstructured":"Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A (2020) Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. Int J Mol Sci 21(18). https:\/\/doi.org\/10.3390\/ijms21186454","DOI":"10.3390\/ijms21186454"},{"key":"3563_CR43","doi-asserted-by":"publisher","first-page":"585880","DOI":"10.3389\/fimmu.2020.585880","volume":"11","author":"P Gough","year":"2020","unstructured":"Gough P, Myles IA (2020) Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects. Front Immunol 11:585880. https:\/\/doi.org\/10.3389\/fimmu.2020.585880","journal-title":"Front Immunol"},{"key":"3563_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2019.00049","volume":"13","author":"N Ort\u00ed-Casa\u00f1","year":"2019","unstructured":"Ort\u00ed-Casa\u00f1 N, Wu Y, Naud\u00e9 PJW, De Deyn PP, Zuhorn IS, Eisel ULM (2019) Targeting TNFR2 as a novel therapeutic strategy for Alzheimer\u2019s disease. Front Neurosci 13:49. https:\/\/doi.org\/10.3389\/fnins.2019.00049","journal-title":"Front Neurosci"},{"key":"3563_CR45","doi-asserted-by":"publisher","first-page":"565841","DOI":"10.3389\/fncel.2020.565841","volume":"14","author":"R Heir","year":"2020","unstructured":"Heir R, Stellwagen D (2020) TNF-mediated homeostatic synaptic plasticity: from in vitro to in vivo models. Front Cell Neurosci 14:565841. https:\/\/doi.org\/10.3389\/fncel.2020.565841","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"3563_CR46","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1034\/j.1600-0404.2001.00053.x","volume":"104","author":"J Zaremba","year":"2001","unstructured":"Zaremba J, Losy J (2001) Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 104(5):288\u2013295. https:\/\/doi.org\/10.1034\/j.1600-0404.2001.00053.x","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"3563_CR47","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/01.str.28.6.1233","volume":"28","author":"FC Barone","year":"1997","unstructured":"Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28(6):1233\u20131244. https:\/\/doi.org\/10.1161\/01.str.28.6.1233","journal-title":"Stroke"},{"issue":"9","key":"3563_CR48","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/jnen\/63.9.942","volume":"63","author":"KL Lambertsen","year":"2004","unstructured":"Lambertsen KL, Gregersen R, Meldgaard M, Clausen BH, Heib\u00f8l EK, Ladeby R, Knudsen J, Frandsen A, et al (2004) A role for interferon-gamma in focal cerebral ischemia in mice. J Neuropathol Exp Neurol 63(9):942\u2013955. https:\/\/doi.org\/10.1093\/jnen\/63.9.942","journal-title":"J Neuropathol Exp Neurol"},{"issue":"17","key":"3563_CR49","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1161\/circulationaha.105.593046","volume":"113","author":"G Yilmaz","year":"2006","unstructured":"Yilmaz G, Arumugam TV, Stokes KY, Granger DN (2006) Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113(17):2105\u20132112. https:\/\/doi.org\/10.1161\/circulationaha.105.593046","journal-title":"Circulation"},{"issue":"20","key":"3563_CR50","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1073\/pnas.92.20.9328","volume":"92","author":"SW Barger","year":"1995","unstructured":"Barger SW, H\u00f6rster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 92(20):9328\u20139332. https:\/\/doi.org\/10.1073\/pnas.92.20.9328","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3563_CR51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"AQ Chen","year":"2019","unstructured":"Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, Xia YP, Jin HJ, et al (2019) Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis 10(7):487. https:\/\/doi.org\/10.1038\/s41419-019-1716-9","journal-title":"Cell Death Dis"},{"issue":"1","key":"3563_CR52","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/s41598-019-38670-z","volume":"9","author":"NR Bonetti","year":"2019","unstructured":"Bonetti NR, Diaz-Ca\u00f1estro C, Liberale L, Crucet M, Akhmedov A, Merlini M, Reiner MF, Gobbato S, et al (2019) Tumour necrosis factor-\u03b1 inhibition improves stroke outcome in a mouse model of rheumatoid arthritis. Sci Rep 9(1):2173. https:\/\/doi.org\/10.1038\/s41598-019-38670-z","journal-title":"Sci Rep"},{"issue":"9","key":"3563_CR53","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","volume":"32","author":"KL Lambertsen","year":"2012","unstructured":"Lambertsen KL, Biber K, Finsen B (2012) Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 32(9):1677\u20131698. https:\/\/doi.org\/10.1038\/jcbfm.2012.88","journal-title":"J Cereb Blood Flow Metab"},{"key":"3563_CR54","doi-asserted-by":"publisher","first-page":"9335166","DOI":"10.1155\/2023\/9335166","volume":"2023","author":"L Mao","year":"2023","unstructured":"Mao L, Wu DH, Hu GH, Fan JH (2023) TLR4 enhances cerebral ischemia\/reperfusion injury via regulating NLRP3 inflammasome and autophagy. Mediators Inflamm 2023:9335166. https:\/\/doi.org\/10.1155\/2023\/9335166","journal-title":"Mediators Inflamm"},{"key":"3563_CR55","doi-asserted-by":"publisher","unstructured":"Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, Warsz-Wianecka A, Zareba K, Puz P, Bal W, Pawletko K, et al (2019) The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol 70(2). https:\/\/doi.org\/10.26402\/jpp.2019.2.04","DOI":"10.26402\/jpp.2019.2.04"},{"issue":"6","key":"3563_CR56","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10753-010-9262-8","volume":"34","author":"BN Manolescu","year":"2011","unstructured":"Manolescu BN, Berteanu M, Dumitru L, Dinu H, Iliescu A, F\u0103rc\u0103\u015fanu IC, Oprea E, Vl\u0103doiu S, et al (2011) Dynamics of inflammatory markers in post-acute stroke patients undergoing rehabilitation. Inflammation 34(6):551\u2013558. https:\/\/doi.org\/10.1007\/s10753-010-9262-8","journal-title":"Inflammation"},{"issue":"7","key":"3563_CR57","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/aps.2018.26","volume":"39","author":"A Hu\u0163anu","year":"2018","unstructured":"Hu\u0163anu A, Iancu M, B\u0103la\u015fa R, Maier S, Dobreanu M (2018) Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-Dimers, NGAL and NSE measured using a biochip array. Acta Pharmacol Sin 39(7):1228\u20131236. https:\/\/doi.org\/10.1038\/aps.2018.26","journal-title":"Acta Pharmacol Sin"},{"key":"3563_CR58","doi-asserted-by":"publisher","first-page":"8230298","DOI":"10.1155\/2017\/8230298","volume":"2017","author":"JC Rosa Neto","year":"2017","unstructured":"Rosa Neto JC, Lira FS, Roy S, Festuccia W (2017) Immunometabolism: molecular mechanisms, diseases, and therapies 2016. Mediators Inflamm 2017:8230298. https:\/\/doi.org\/10.1155\/2017\/8230298","journal-title":"Mediators Inflamm"},{"issue":"10","key":"3563_CR59","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1161\/strokeaha.117.017849","volume":"48","author":"EH Svensson","year":"2017","unstructured":"Svensson EH, S\u00f6derholm M, Abul-Kasim K, Engstr\u00f6m G (2017) Tumor necrosis factor receptor 1 and 2 are associated with risk of intracerebral hemorrhage. Stroke 48(10):2710\u20132715. https:\/\/doi.org\/10.1161\/strokeaha.117.017849","journal-title":"Stroke"},{"key":"3563_CR60","doi-asserted-by":"publisher","unstructured":"Hansen RB, Laursen CCH, Nawaz N, Madsen JS, Nielsen HH, Kruuse C, M\u00f8ller A, Degn M, et al (2021) Leukocyte TNFR1 and TNFR2 expression contributes to the peripheral immune response in cases with ischemic stroke. Cells 10(4). https:\/\/doi.org\/10.3390\/cells10040861","DOI":"10.3390\/cells10040861"},{"issue":"1","key":"3563_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-020-00957-y","volume":"8","author":"BH Clausen","year":"2020","unstructured":"Clausen BH, Wirenfeldt M, H\u00f8gedal SS, Frich LH, Nielsen HH, Schr\u00f8der HD, \u00d8stergaard K, Finsen B, et al (2020) Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke. Acta Neuropathol Commun 8(1):81. https:\/\/doi.org\/10.1186\/s40478-020-00957-y","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"3563_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ajh\/hpw134","volume":"30","author":"HL Kim","year":"2017","unstructured":"Kim HL, Lee JP, An JN, Kim JH, Lim WH, Seo JB, Chung WY, Oh YK, et al (2017) Soluble tumor necrosis factor receptors and arterial stiffness in patients with coronary atherosclerosis. Am J Hypertens 30(3):313\u2013318. https:\/\/doi.org\/10.1093\/ajh\/hpw134","journal-title":"Am J Hypertens"},{"issue":"3","key":"3563_CR63","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/strokeaha.115.012166","volume":"47","author":"AK Boehme","year":"2016","unstructured":"Boehme AK, McClure LA, Zhang Y, Luna JM, Del Brutto OH, Benavente OR, Elkind MS (2016) Inflammatory markers and outcomes after lacunar stroke: levels of inflammatory markers in treatment of stroke study. Stroke 47(3):659\u2013667. https:\/\/doi.org\/10.1161\/strokeaha.115.012166","journal-title":"Stroke"},{"key":"3563_CR64","doi-asserted-by":"publisher","unstructured":"Lin SY, Wang YY, Chang CY, Wu CC, Chen WY, Liao SL, Chen CJ (2021) TNF-\u03b1 receptor inhibitor alleviates metabolic and inflammatory changes in a rat model of ischemic stroke. Antioxidants (Basel) 10(6). https:\/\/doi.org\/10.3390\/antiox10060851","DOI":"10.3390\/antiox10060851"},{"key":"3563_CR65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12974-014-0203-6","volume":"11","author":"BH Clausen","year":"2014","unstructured":"Clausen BH, Degn M, Martin NA, Couch Y, Karimi L, Ormh\u00f8j M, Mortensen ML, Gredal HB, et al (2014) Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia. J Neuroinflammation 11:203. https:\/\/doi.org\/10.1186\/s12974-014-0203-6","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3563_CR66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/14737175.2020.1727742","volume":"20","author":"IA Clark","year":"2020","unstructured":"Clark IA (2020) Randomized controlled trial validating the use of perispinal etanercept to reduce post-stroke disability has wide-ranging implications. Expert Rev Neurother 20(3):203\u2013205. https:\/\/doi.org\/10.1080\/14737175.2020.1727742","journal-title":"Expert Rev Neurother"},{"key":"3563_CR67","doi-asserted-by":"publisher","first-page":"831910","DOI":"10.3389\/fnagi.2022.831910","volume":"14","author":"R Duan","year":"2022","unstructured":"Duan R, Wang N, Shang Y, Li H, Liu Q, Li L, Zhao X (2022) TNF-\u03b1 (G-308A) Polymorphism, circulating levels of TNF-\u03b1 and IGF-1: risk factors for ischemic stroke-an updated meta-analysis. Front Aging Neurosci 14:831910. https:\/\/doi.org\/10.3389\/fnagi.2022.831910","journal-title":"Front Aging Neurosci"},{"key":"3563_CR68","doi-asserted-by":"publisher","first-page":"105827","DOI":"10.1016\/j.intimp.2019.105827","volume":"75","author":"JC Wu","year":"2019","unstructured":"Wu JC, Zhang X, Wang JH, Liu QW, Wang XQ, Wu ZQ, Wang J, Zhang C, et al (2019) Gene polymorphisms and circulating levels of the TNF-alpha are associated with ischemic stroke: a meta-analysis based on 19,873 individuals. Int Immunopharmacol 75:105827. https:\/\/doi.org\/10.1016\/j.intimp.2019.105827","journal-title":"Int Immunopharmacol"},{"key":"3563_CR69","doi-asserted-by":"publisher","first-page":"808012","DOI":"10.3389\/fimmu.2021.808012","volume":"12","author":"T Macleod","year":"2021","unstructured":"Macleod T, Berekmeri A, Bridgewood C, Stacey M, McGonagle D, Wittmann M (2021) The immunological impact of IL-1 family cytokines on the epidermal barrier. Front Immunol 12:808012. https:\/\/doi.org\/10.3389\/fimmu.2021.808012","journal-title":"Front Immunol"},{"issue":"6","key":"3563_CR70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.smim.2013.10.001","volume":"25","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA (2013) Overview of the interleukin-1 family of ligands and receptors. Semin Immunol 25(6):389\u2013393. https:\/\/doi.org\/10.1016\/j.smim.2013.10.001","journal-title":"Semin Immunol"},{"issue":"3","key":"3563_CR71","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2217\/imt.14.106","volume":"7","author":"T Satoh","year":"2015","unstructured":"Satoh T, Otsuka A, Contassot E, French LE (2015) The inflammasome and IL-1\u03b2: implications for the treatment of inflammatory diseases. Immunotherapy 7(3):243\u2013254. https:\/\/doi.org\/10.2217\/imt.14.106","journal-title":"Immunotherapy"},{"issue":"3","key":"3563_CR72","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4103\/0972-2327.99707","volume":"15","author":"AR Nayak","year":"2012","unstructured":"Nayak AR, Kashyap RS, Kabra D, Purohit HJ, Taori GM, Daginawala HF (2012) Time course of inflammatory cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome. Ann Indian Acad Neurol 15(3):181\u2013185. https:\/\/doi.org\/10.4103\/0972-2327.99707","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"3563_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/npp.2016.169","volume":"42","author":"J Barnes","year":"2017","unstructured":"Barnes J, Mondelli V, Pariante CM (2017) Genetic contributions of inflammation to depression. Neuropsychopharmacology 42(1):81\u201398. https:\/\/doi.org\/10.1038\/npp.2016.169","journal-title":"Neuropsychopharmacology"},{"key":"3563_CR74","doi-asserted-by":"publisher","first-page":"578879","DOI":"10.3389\/fimmu.2020.578879","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Ma K, Zhang C, Liu Y, Liang F, Hu W, Bian X, Yang S, Fu X (2020) Burns impair blood-brain barrier and mesenchymal stem cells can reverse the process in mice. Front Immunol 11:578879. https:\/\/doi.org\/10.3389\/fimmu.2020.578879","journal-title":"Front Immunol"},{"issue":"6","key":"3563_CR75","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.4049\/jimmunol.179.6.4125","volume":"179","author":"G Liu","year":"2007","unstructured":"Liu G, Tsuruta Y, Gao Z, Park YJ, Abraham E (2007) Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. J Immunol 179(6):4125\u20134134. https:\/\/doi.org\/10.4049\/jimmunol.179.6.4125","journal-title":"J Immunol"},{"issue":"38","key":"3563_CR76","doi-asserted-by":"publisher","first-page":"25900","DOI":"10.1074\/jbc.M707692200","volume":"283","author":"CM Cahill","year":"2008","unstructured":"Cahill CM, Rogers JT (2008) Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT\/IkappaB kinase alpha pathway targeting activator protein-1. J Biol Chem 283(38):25900\u201325912. https:\/\/doi.org\/10.1074\/jbc.M707692200","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"3563_CR77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jneuroim.2005.04.025","volume":"165","author":"V Chaparro-Huerta","year":"2005","unstructured":"Chaparro-Huerta V, Rivera-Cervantes MC, Flores-Soto ME, G\u00f3mez-Pinedo U, Beas-Z\u00e1rate C (2005) Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. J Neuroimmunol 165(1\u20132):53\u201362. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.04.025","journal-title":"J Neuroimmunol"},{"issue":"6","key":"3563_CR78","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.peptides.2007.03.021","volume":"28","author":"W Li","year":"2007","unstructured":"Li W, Zheng S, Tang C, Zhu Y, Wang X (2007) JNK-AP-1 pathway involved in interleukin-1beta-induced calcitonin gene-related peptide secretion in human type II alveolar epithelial cells. Peptides 28(6):1252\u20131259. https:\/\/doi.org\/10.1016\/j.peptides.2007.03.021","journal-title":"Peptides"},{"key":"3563_CR79","doi-asserted-by":"publisher","first-page":"111467","DOI":"10.1016\/j.mad.2021.111467","volume":"195","author":"S Cicolari","year":"2021","unstructured":"Cicolari S, Catapano AL, Magni P (2021) Inflammaging and neurodegenerative diseases: Role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease. Mech Ageing Dev 195:111467. https:\/\/doi.org\/10.1016\/j.mad.2021.111467","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"3563_CR80","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.immuni.2021.02.004","volume":"54","author":"S Roth","year":"2021","unstructured":"Roth S, Cao J, Singh V, Tiedt S, Hundeshagen G, Li T, Boehme JD, Chauhan D, et al (2021) Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade. Immunity 54(4):648-659.e648. https:\/\/doi.org\/10.1016\/j.immuni.2021.02.004","journal-title":"Immunity"},{"issue":"11","key":"3563_CR81","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/eji.201848070","volume":"49","author":"BR Sharma","year":"2019","unstructured":"Sharma BR, Karki R, Kanneganti TD (2019) Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur J Immunol 49(11):1998\u20132011. https:\/\/doi.org\/10.1002\/eji.201848070","journal-title":"Eur J Immunol"},{"issue":"6","key":"3563_CR82","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000332205","volume":"32","author":"A Denes","year":"2011","unstructured":"Denes A, Pinteaux E, Rothwell NJ, Allan SM (2011) Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target. Cerebrovasc Dis 32(6):517\u2013527. https:\/\/doi.org\/10.1159\/000332205","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"3563_CR83","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2008.05.042","volume":"203","author":"J Protopsaltis","year":"2009","unstructured":"Protopsaltis J, Kokkoris S, Korantzopoulos P, Milionis HJ, Karzi E, Anastasopoulou A, Filioti K, Antonopoulos S, et al (2009) Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke. Atherosclerosis 203(1):228\u2013235. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.05.042","journal-title":"Atherosclerosis"},{"issue":"1","key":"3563_CR84","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12028-013-9899-x","volume":"21","author":"KJ Becker","year":"2014","unstructured":"Becker KJ, Dankwa D, Lee R, Schulze J, Zierath D, Tanzi P, Cain K, Dressel A, et al (2014) Stroke, IL-1ra, IL1RN, infection and outcome. Neurocrit Care 21(1):140\u2013146. https:\/\/doi.org\/10.1007\/s12028-013-9899-x","journal-title":"Neurocrit Care"},{"issue":"10","key":"3563_CR85","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1\u20132","key":"3563_CR86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0165-5728(03)00134-6","volume":"139","author":"HC Emsley","year":"2003","unstructured":"Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, del Zoppo GJ, et al (2003) An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139(1\u20132):93\u2013101. https:\/\/doi.org\/10.1016\/s0165-5728(03)00134-6","journal-title":"J Neuroimmunol"},{"key":"3563_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2377-4-2","volume":"4","author":"CJ Smith","year":"2004","unstructured":"Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, et al (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4:2. https:\/\/doi.org\/10.1186\/1471-2377-4-2","journal-title":"BMC Neurol"},{"key":"3563_CR88","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fncel.2019.00201","volume":"13","author":"H Yao","year":"2019","unstructured":"Yao H, Zhang Y, Shu H, Xie B, Tao Y, Yuan Y, Shang Y, Yuan S, Zhang J (2019) Hyperforin promotes post-stroke neuroangiogenesis via astrocytic IL-6-mediated negative immune regulation in the ischemic brain. Front Cell Neurosci 13:201. https:\/\/doi.org\/10.3389\/fncel.2019.00201","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"3563_CR89","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254\u20131266. https:\/\/doi.org\/10.7150\/ijbs.4679","journal-title":"Int J Biol Sci"},{"key":"3563_CR90","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neulet.2013.04.037","volume":"548","author":"L Zeng","year":"2013","unstructured":"Zeng L, Wang Y, Liu J, Wang L, Weng S, Chen K, Domino EF, Yang GY (2013) Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neurosci Lett 548:4\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2013.04.037","journal-title":"Neurosci Lett"},{"issue":"5","key":"3563_CR91","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1212\/wnl.0000000000011268","volume":"96","author":"L Mechtouff","year":"2021","unstructured":"Mechtouff L, Bochaton T, Paccalet A, Da Silva CC, Buisson M, Amaz C, Derex L, Ong E, et al (2021) Association of interleukin-6 levels and futile reperfusion after mechanical thrombectomy. Neurology 96(5):e752\u2013e757. https:\/\/doi.org\/10.1212\/wnl.0000000000011268","journal-title":"Neurology"},{"issue":"20","key":"3563_CR92","doi-asserted-by":"publisher","first-page":"e2375","DOI":"10.1212\/wnl.0000000000007416","volume":"92","author":"NS Jenny","year":"2019","unstructured":"Jenny NS, Callas PW, Judd SE, McClure LA, Kissela B, Zakai NA, Cushman M (2019) Inflammatory cytokines and ischemic stroke risk: the REGARDS cohort. Neurology 92(20):e2375\u2013e2384. https:\/\/doi.org\/10.1212\/wnl.0000000000007416","journal-title":"Neurology"},{"issue":"1","key":"3563_CR93","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12975-018-0617-z","volume":"10","author":"WM Armstead","year":"2019","unstructured":"Armstead WM, Hekierski H, Pastor P, Yarovoi S, Higazi AA, Cines DB (2019) Release of IL-6 after stroke contributes to impaired cerebral autoregulation and hippocampal neuronal necrosis through NMDA receptor activation and upregulation of ET-1 and JNK. Transl Stroke Res 10(1):104\u2013111. https:\/\/doi.org\/10.1007\/s12975-018-0617-z","journal-title":"Transl Stroke Res"},{"issue":"3","key":"3563_CR94","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/jcbfm.2008.141","volume":"29","author":"S Suzuki","year":"2009","unstructured":"Suzuki S, Tanaka K, Suzuki N (2009) Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 29(3):464\u2013479. https:\/\/doi.org\/10.1038\/jcbfm.2008.141","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 6","key":"3563_CR95","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/brain\/aws075","volume":"135","author":"K Gertz","year":"2012","unstructured":"Gertz K, Kronenberg G, K\u00e4lin RE, Baldinger T, Werner C, Balkaya M, Eom GD, Hellmann-Regen J, et al (2012) Essential role of interleukin-6 in post-stroke angiogenesis. Brain 135(Pt 6):1964\u20131980. https:\/\/doi.org\/10.1093\/brain\/aws075","journal-title":"Brain"},{"issue":"1","key":"3563_CR96","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40478-016-0371-y","volume":"4","author":"TV Nguyen","year":"2016","unstructured":"Nguyen TV, Frye JB, Zbesko JC, Stepanovic K, Hayes M, Urzua A, Serrano G, Beach TG, et al (2016) Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue. Acta Neuropathol Commun 4(1):100. https:\/\/doi.org\/10.1186\/s40478-016-0371-y","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"3563_CR97","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1471-4159.2009.06098.x","volume":"110","author":"F de Bilbao","year":"2009","unstructured":"de Bilbao F, Arsenijevic D, Moll T, Garcia-Gabay I, Vallet P, Langhans W, Giannakopoulos P (2009) In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice. J Neurochem 110(1):12\u201322. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06098.x","journal-title":"J Neurochem"},{"issue":"12","key":"3563_CR98","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/jcbfm.2013.155","volume":"33","author":"I P\u00e9rez-de Puig","year":"2013","unstructured":"P\u00e9rez-de Puig I, Mir\u00f3 F, Salas-Perdomo A, Bonfill-Teixidor E, Ferrer-Ferrer M, M\u00e1rquez-Kisinousky L, Planas AM (2013) IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion. J Cereb Blood Flow Metab 33(12):1955\u20131966. https:\/\/doi.org\/10.1038\/jcbfm.2013.155","journal-title":"J Cereb Blood Flow Metab"},{"key":"3563_CR99","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.brainres.2010.11.096","volume":"1373","author":"S Sharma","year":"2011","unstructured":"Sharma S, Yang B, Xi X, Grotta JC, Aronowski J, Savitz SI (2011) IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res 1373:189\u2013194. https:\/\/doi.org\/10.1016\/j.brainres.2010.11.096","journal-title":"Brain Res"},{"issue":"1","key":"3563_CR100","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2249.2004.02342.x","volume":"135","author":"F Driessler","year":"2004","unstructured":"Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ (2004) Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol 135(1):64\u201373. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02342.x","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"3563_CR101","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11011-013-9413-3","volume":"28","author":"S Bodhankar","year":"2013","unstructured":"Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H (2013) IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis 28(3):375\u2013386. https:\/\/doi.org\/10.1007\/s11011-013-9413-3","journal-title":"Metab Brain Dis"},{"key":"3563_CR102","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fncel.2015.00361","volume":"9","author":"J Wang","year":"2015","unstructured":"Wang J, Xie L, Yang C, Ren C, Zhou K, Wang B, Zhang Z, Wang Y, et al (2015) Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10. Front Cell Neurosci 9:361. https:\/\/doi.org\/10.3389\/fncel.2015.00361","journal-title":"Front Cell Neurosci"},{"issue":"44","key":"3563_CR103","doi-asserted-by":"publisher","first-page":"17350","DOI":"10.1523\/jneurosci.4901-12.2013","volume":"33","author":"A Liesz","year":"2013","unstructured":"Liesz A, Zhou W, Na SY, H\u00e4mmerling GJ, Garbi N, Karcher S, Mracsko E, Backs J, et al (2013) Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J Neurosci 33(44):17350\u201317362. https:\/\/doi.org\/10.1523\/jneurosci.4901-12.2013","journal-title":"J Neurosci"},{"issue":"4","key":"3563_CR104","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1182\/blood-2012-04-426734","volume":"121","author":"C Kleinschnitz","year":"2013","unstructured":"Kleinschnitz C, Kraft P, Dreykluft A, Hagedorn I, G\u00f6bel K, Schuhmann MK, Langhauser F, Helluy X, et al (2013) Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 121(4):679\u2013691. https:\/\/doi.org\/10.1182\/blood-2012-04-426734","journal-title":"Blood"},{"issue":"1","key":"3563_CR105","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/geno.1998.5336","volume":"51","author":"KF Nolan","year":"1998","unstructured":"Nolan KF, Greaves DR, Waldmann H (1998) The human interleukin 18 gene IL18 maps to 11q22.2\u2013q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 51(1):161\u2013163. https:\/\/doi.org\/10.1006\/geno.1998.5336","journal-title":"Genomics"},{"issue":"6552","key":"3563_CR106","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/378088a0","volume":"378","author":"H Okamura","year":"1995","unstructured":"Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K et al (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378(6552):88\u201391. https:\/\/doi.org\/10.1038\/378088a0","journal-title":"Nature"},{"issue":"3","key":"3563_CR107","doi-asserted-by":"publisher","first-page":"F11","DOI":"10.1084\/jem.194.3.f11","volume":"194","author":"SL Swain","year":"2001","unstructured":"Swain SL (2001) Interleukin 18: tipping the balance towards a T helper cell 1 response. J Exp Med 194(3):F11-14. https:\/\/doi.org\/10.1084\/jem.194.3.f11","journal-title":"J Exp Med"},{"issue":"18","key":"3563_CR108","doi-asserted-by":"publisher","first-page":"7457","DOI":"10.18632\/aging.102253","volume":"11","author":"Y Hao","year":"2019","unstructured":"Hao Y, Ding J, Hong R, Bai S, Wang Z, Mo C, Hu Q, Li Z, et al (2019) Increased interleukin-18 level contributes to the development and severity of ischemic stroke. Aging (Albany NY) 11(18):7457\u20137472. https:\/\/doi.org\/10.18632\/aging.102253","journal-title":"Aging (Albany NY)"},{"key":"3563_CR109","doi-asserted-by":"publisher","first-page":"919973","DOI":"10.3389\/fimmu.2022.919973","volume":"13","author":"SA Ihim","year":"2022","unstructured":"Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, Azizi G (2022) Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Front Immunol 13:919973. https:\/\/doi.org\/10.3389\/fimmu.2022.919973","journal-title":"Front Immunol"},{"issue":"3","key":"3563_CR110","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molmed.2014.11.008","volume":"21","author":"P Gurung","year":"2015","unstructured":"Gurung P, Lukens JR, Kanneganti TD (2015) Mitochondria: diversity in the regulation of the NLRP3 inflammasome. Trends Mol Med 21(3):193\u2013201. https:\/\/doi.org\/10.1016\/j.molmed.2014.11.008","journal-title":"Trends Mol Med"},{"issue":"12","key":"3563_CR111","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.4049\/jimmunol.1202121","volume":"189","author":"L Bossaller","year":"2012","unstructured":"Bossaller L, Chiang PI, Schmidt-Lauber C, Ganesan S, Kaiser WJ, Rathinam VA, Mocarski ES, Subramanian D, et al (2012) Cutting edge: FAS (CD95) mediates noncanonical IL-1\u03b2 and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol 189(12):5508\u20135512. https:\/\/doi.org\/10.4049\/jimmunol.1202121","journal-title":"J Immunol"},{"issue":"11","key":"3563_CR112","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.4049\/jimmunol.167.11.6568","volume":"167","author":"S Sugawara","year":"2001","unstructured":"Sugawara S, Uehara A, Nochi T, Yamaguchi T, Ueda H, Sugiyama A, Hanzawa K, Kumagai K, et al (2001) Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 167(11):6568\u20136575. https:\/\/doi.org\/10.4049\/jimmunol.167.11.6568","journal-title":"J Immunol"},{"issue":"12","key":"3563_CR113","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.4049\/jimmunol.177.12.8315","volume":"177","author":"Y Omoto","year":"2006","unstructured":"Omoto Y, Tokime K, Yamanaka K, Habe K, Morioka T, Kurokawa I, Tsutsui H, Yamanishi K, et al (2006) Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J Immunol 177(12):8315\u20138319. https:\/\/doi.org\/10.4049\/jimmunol.177.12.8315","journal-title":"J Immunol"},{"issue":"2","key":"3563_CR114","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jdermsci.2010.05.004","volume":"59","author":"Y Omoto","year":"2010","unstructured":"Omoto Y, Yamanaka K, Tokime K, Kitano S, Kakeda M, Akeda T, Kurokawa I, Gabazza EC, et al (2010) Granzyme B is a novel interleukin-18 converting enzyme. J Dermatol Sci 59(2):129\u2013135. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.05.004","journal-title":"J Dermatol Sci"},{"issue":"6","key":"3563_CR115","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41419-022-04907-5","volume":"13","author":"G Rackov","year":"2022","unstructured":"Rackov G, Tavakoli Zaniani P, Colomo Del Pino S, Shokri R, Monserrat J, Alvarez-Mon M, Martinez AC, Balomenos D (2022) Mitochondrial reactive oxygen is critical for IL-12\/IL-18-induced IFN-\u03b3 production by CD4(+) T cells and is regulated by Fas\/FasL signaling. Cell Death Dis 13(6):531. https:\/\/doi.org\/10.1038\/s41419-022-04907-5","journal-title":"Cell Death Dis"},{"issue":"1","key":"3563_CR116","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3892\/ijmm.2020.4779","volume":"47","author":"H Ding","year":"2021","unstructured":"Ding H, Li Y, Wen M, Liu X, Han Y, Zeng H (2021) Elevated intracranial pressure induces IL-1\u03b2 and IL-18 overproduction via activation of the NLRP3 inflammasome in microglia of ischemic adult rats. Int J Mol Med 47(1):183\u2013194. https:\/\/doi.org\/10.3892\/ijmm.2020.4779","journal-title":"Int J Mol Med"},{"issue":"1","key":"3563_CR117","doi-asserted-by":"publisher","first-page":"198","DOI":"10.12669\/pjms.311.5997","volume":"31","author":"JH Shi","year":"2015","unstructured":"Shi JH, Niu LD, Chen XY, Hou JY, Yang P, Li GP (2015) Investigation on the IL-18 -607A\/C and -137C\/G on the susceptibility of ischemic stroke. Pak J Med Sci 31(1):198\u2013202. https:\/\/doi.org\/10.12669\/pjms.311.5997","journal-title":"Pak J Med Sci"},{"issue":"5651","key":"3563_CR118","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1088417","volume":"302","author":"ML Monje","year":"2003","unstructured":"Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302(5651):1760\u20131765. https:\/\/doi.org\/10.1126\/science.1088417","journal-title":"Science"},{"issue":"2","key":"3563_CR119","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ijnp\/pyx083","volume":"21","author":"A Borsini","year":"2018","unstructured":"Borsini A, Cattaneo A, Malpighi C, Thuret S, Harrison NA, Zunszain PA, Pariante CM (2018) Interferon-alpha reduces human hippocampal neurogenesis and increases apoptosis via activation of distinct STAT1-dependent mechanisms. Int J Neuropsychopharmacol 21(2):187\u2013200. https:\/\/doi.org\/10.1093\/ijnp\/pyx083","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"3563_CR120","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1134\/s0006297921020048","volume":"86","author":"AP Bolshakov","year":"2021","unstructured":"Bolshakov AP, Tret\u2019yakova LV, Kvichansky AA, Gulyaeva NV (2021) Glucocorticoids: Dr. Jekyll and Mr. Hyde of hippocampal neuroinflammation. Biochemistry (Mosc) 86(2):156\u2013167. https:\/\/doi.org\/10.1134\/s0006297921020048","journal-title":"Biochemistry (Mosc)"},{"issue":"6","key":"3563_CR121","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s11064-018-2662-0","volume":"44","author":"NV Gulyaeva","year":"2019","unstructured":"Gulyaeva NV (2019) Functional neurochemistry of the ventral and dorsal hippocampus: stress, depression, dementia and remote hippocampal damage. Neurochem Res 44(6):1306\u20131322. https:\/\/doi.org\/10.1007\/s11064-018-2662-0","journal-title":"Neurochem Res"},{"issue":"6","key":"3563_CR122","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/mp.2015.69","volume":"21","author":"L Schmaal","year":"2016","unstructured":"Schmaal L, Veltman DJ, van Erp TG, S\u00e4mann PG, Frodl T, Jahanshad N, Loehrer E, Tiemeier H, et al (2016) Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry 21(6):806\u2013812. https:\/\/doi.org\/10.1038\/mp.2015.69","journal-title":"Mol Psychiatry"},{"key":"3563_CR123","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuroscience.2018.03.034","volume":"403","author":"M Woelfer","year":"2019","unstructured":"Woelfer M, Kasties V, Kahlfuss S, Walter M (2019) The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder. Neuroscience 403:93\u2013110. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.03.034","journal-title":"Neuroscience"},{"issue":"1","key":"3563_CR124","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R Troubat","year":"2021","unstructured":"Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, El Hage W, et al (2021) Neuroinflammation and depression: a review. Eur J Neurosci 53(1):151\u2013171. https:\/\/doi.org\/10.1111\/ejn.14720","journal-title":"Eur J Neurosci"},{"issue":"11","key":"3563_CR125","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1056\/NEJMp068126","volume":"356","author":"K Christensen","year":"2007","unstructured":"Christensen K, Murray JC (2007) What genome-wide association studies can do for medicine. N Engl J Med 356(11):1094\u20131097. https:\/\/doi.org\/10.1056\/NEJMp068126","journal-title":"N Engl J Med"},{"issue":"1","key":"3563_CR126","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cytogfr.2008.11.006","volume":"20","author":"AJ Smith","year":"2009","unstructured":"Smith AJ, Humphries SE (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20(1):43\u201359. https:\/\/doi.org\/10.1016\/j.cytogfr.2008.11.006","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1\u20133","key":"3563_CR127","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jad.2009.02.017","volume":"119","author":"L Capuron","year":"2009","unstructured":"Capuron L, Fornwalt FB, Knight BT, Harvey PD, Ninan PT, Miller AH (2009) Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord 119(1\u20133):181\u2013185. https:\/\/doi.org\/10.1016\/j.jad.2009.02.017","journal-title":"J Affect Disord"},{"issue":"6","key":"3563_CR128","doi-asserted-by":"publisher","first-page":"e0197267","DOI":"10.1371\/journal.pone.0197267","volume":"13","author":"W Zou","year":"2018","unstructured":"Zou W, Feng R, Yang Y (2018) Changes in the serum levels of inflammatory cytokines in antidepressant drug-na\u00efve patients with major depression. PLoS One 13(6):e0197267. https:\/\/doi.org\/10.1371\/journal.pone.0197267","journal-title":"PLoS One"},{"key":"3563_CR129","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","volume":"81","author":"D Enache","year":"2019","unstructured":"Enache D, Pariante CM, Mondelli V (2019) Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun 81:24\u201340. https:\/\/doi.org\/10.1016\/j.bbi.2019.06.015","journal-title":"Brain Behav Immun"},{"issue":"7","key":"3563_CR130","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/npp.2014.25","volume":"39","author":"E Haroon","year":"2014","unstructured":"Haroon E, Woolwine BJ, Chen X, Pace TW, Parekh S, Spivey JR, Hu XP, Miller AH (2014) IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacology 39(7):1777\u20131785. https:\/\/doi.org\/10.1038\/npp.2014.25","journal-title":"Neuropsychopharmacology"},{"key":"3563_CR131","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbi.2018.02.003","volume":"69","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Desse S, Martinez A, Worthen RJ, Jope RS, Beurel E (2018) TNF\u03b1 disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun 69:556\u2013567. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.003","journal-title":"Brain Behav Immun"},{"issue":"4","key":"3563_CR132","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neubiorev.2013.02.004","volume":"37","author":"H Liu","year":"2013","unstructured":"Liu H, Luiten PG, Eisel UL, Dejongste MJ, Schoemaker RG (2013) Depression after myocardial infarction: TNF-\u03b1-induced alterations of the blood-brain barrier and its putative therapeutic implications. Neurosci Biobehav Rev 37(4):561\u2013572. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.02.004","journal-title":"Neurosci Biobehav Rev"},{"issue":"1\u20132","key":"3563_CR133","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brainres.2004.11.014","volume":"1034","author":"JY Zou","year":"2005","unstructured":"Zou JY, Crews FT (2005) TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res 1034(1\u20132):11\u201324. https:\/\/doi.org\/10.1016\/j.brainres.2004.11.014","journal-title":"Brain Res"},{"issue":"4","key":"3563_CR134","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000026615","volume":"40","author":"J Levine","year":"1999","unstructured":"Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V (1999) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40(4):171\u2013176. https:\/\/doi.org\/10.1159\/000026615","journal-title":"Neuropsychobiology"},{"issue":"1","key":"3563_CR135","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1176\/appi.ajp.162.1.175","volume":"162","author":"AJ Thomas","year":"2005","unstructured":"Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O\u2019Brien JT (2005) Increase in interleukin-1beta in late-life depression. Am J Psychiatry 162(1):175\u2013177. https:\/\/doi.org\/10.1176\/appi.ajp.162.1.175","journal-title":"Am J Psychiatry"},{"key":"3563_CR136","doi-asserted-by":"publisher","first-page":"102982","DOI":"10.1016\/j.msard.2021.102982","volume":"52","author":"AM Ferreira","year":"2021","unstructured":"Ferreira AM, Leal B, Ferreira I, Br\u00e1s S, Moreira I, Sam\u00f5es R, Sousa AP, Santos E, et al (2021) Depression and anxiety in multiple sclerosis patients: the role of genetic variability of interleukin 1\u03b2. Mult Scler Relat Disord 52:102982. https:\/\/doi.org\/10.1016\/j.msard.2021.102982","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"3563_CR137","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12974-017-0865-y","volume":"14","author":"N Yue","year":"2017","unstructured":"Yue N, Huang H, Zhu X, Han Q, Wang Y, Li B, Liu Q, Wu G, et al (2017) Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors. J Neuroinflammation 14(1):102. https:\/\/doi.org\/10.1186\/s12974-017-0865-y","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3563_CR138","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1753425910377101","volume":"18","author":"M Seil","year":"2012","unstructured":"Seil M, El Ouaaliti M, Abdou Foumekoye S, Pochet S, Dehaye JP (2012) Distinct regulation by lipopolysaccharides of the expression of interleukin-1\u03b2 by murine macrophages and salivary glands. Innate Immun 18(1):14\u201324. https:\/\/doi.org\/10.1177\/1753425910377101","journal-title":"Innate Immun"},{"issue":"2","key":"3563_CR139","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1523\/jneurosci.3295-09.2010","volume":"30","author":"AK Clark","year":"2010","unstructured":"Clark AK, Staniland AA, Marchand F, Kaan TK, McMahon SB, Malcangio M (2010) P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. J Neurosci 30(2):573\u2013582. https:\/\/doi.org\/10.1523\/jneurosci.3295-09.2010","journal-title":"J Neurosci"},{"key":"3563_CR140","doi-asserted-by":"publisher","unstructured":"Ribeiro DE, Roncalho AL, Glaser T, Ulrich H, Wegener G, Joca S (2019) P2X7 receptor signaling in stress and depression. Int J Mol Sci 20(11). https:\/\/doi.org\/10.3390\/ijms20112778","DOI":"10.3390\/ijms20112778"},{"issue":"1\u20132","key":"3563_CR141","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.psychres.2007.12.004","volume":"167","author":"Y Ovaskainen","year":"2009","unstructured":"Ovaskainen Y, Koponen H, Jokelainen J, Kein\u00e4nen-Kiukaanniemi S, Kumpusalo E, Vanhala M (2009) Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males. Psychiatry Res 167(1\u20132):73\u201379. https:\/\/doi.org\/10.1016\/j.psychres.2007.12.004","journal-title":"Psychiatry Res"},{"issue":"1\u20133","key":"3563_CR142","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0165-0327(00)00157-9","volume":"63","author":"M Rothermundt","year":"2001","unstructured":"Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H (2001) Inflammatory markers in major depression and melancholia. J Affect Disord 63(1\u20133):93\u2013102. https:\/\/doi.org\/10.1016\/s0165-0327(00)00157-9","journal-title":"J Affect Disord"},{"issue":"2","key":"3563_CR143","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000054867","volume":"43","author":"A Kagaya","year":"2001","unstructured":"Kagaya A, Kugaya A, Takebayashi M, Fukue-Saeki M, Saeki T, Yamawaki S, Uchitomi Y (2001) Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 43(2):59\u201362. https:\/\/doi.org\/10.1159\/000054867","journal-title":"Neuropsychobiology"},{"issue":"6","key":"3563_CR144","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1073\/pnas.0910658107","volume":"107","author":"JW Koo","year":"2010","unstructured":"Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS (2010) Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A 107(6):2669\u20132674. https:\/\/doi.org\/10.1073\/pnas.0910658107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3563_CR145","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1007\/s12035-015-9408-7","volume":"53","author":"E Alcocer-G\u00f3mez","year":"2016","unstructured":"Alcocer-G\u00f3mez E, Ulecia-Mor\u00f3n C, Mar\u00edn-Aguilar F, Rybkina T, Casas-Barquero N, Ruiz-Cabello J, Ryffel B, Apetoh L, Ghiringhelli F, et al (2016) Stress-induced depressive behaviors require a functional NLRP3 inflammasome. Mol Neurobiol 53(7):4874\u20134882. https:\/\/doi.org\/10.1007\/s12035-015-9408-7","journal-title":"Mol Neurobiol"},{"key":"3563_CR146","doi-asserted-by":"publisher","unstructured":"Zhou L, Zhang J, Han X, Fang J, Zhou S, Lu L, Shi Q, Ying H (2022) CysLT(2)R antagonist HAMI 3379 ameliorates post-stroke depression through NLRP3 inflammasome\/pyroptosis pathway in gerbils. Brain Sci 12(8). https:\/\/doi.org\/10.3390\/brainsci12080976","DOI":"10.3390\/brainsci12080976"},{"issue":"2","key":"3563_CR147","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jphs.2021.12.005","volume":"148","author":"S Kitaoka","year":"2022","unstructured":"Kitaoka S (2022) Inflammation in the brain and periphery found in animal models of depression and its behavioral relevance. J Pharmacol Sci 148(2):262\u2013266. https:\/\/doi.org\/10.1016\/j.jphs.2021.12.005","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"3563_CR148","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct\u00f4t KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446\u2013457. https:\/\/doi.org\/10.1016\/j.biopsych.2009.09.033","journal-title":"Biol Psychiatry"},{"key":"3563_CR149","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivim\u00e4ki M (2015) Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206\u2013215. https:\/\/doi.org\/10.1016\/j.bbi.2015.06.001","journal-title":"Brain Behav Immun"},{"key":"3563_CR150","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ynstr.2016.03.003","volume":"4","author":"GE Hodes","year":"2016","unstructured":"Hodes GE, M\u00e9nard C, Russo SJ (2016) Integrating interleukin-6 into depression diagnosis and treatment. Neurobiol Stress 4:15\u201322. https:\/\/doi.org\/10.1016\/j.ynstr.2016.03.003","journal-title":"Neurobiol Stress"},{"issue":"3","key":"3563_CR151","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.nbd.2006.05.001","volume":"23","author":"S Chourbaji","year":"2006","unstructured":"Chourbaji S, Urani A, Inta I, Sanchis-Segura C, Brandwein C, Zink M, Schwaninger M, Gass P (2006) IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis 23(3):587\u2013594. https:\/\/doi.org\/10.1016\/j.nbd.2006.05.001","journal-title":"Neurobiol Dis"},{"issue":"3","key":"3563_CR152","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5498\/wjp.v6.i3.283","volume":"6","author":"SW Jeon","year":"2016","unstructured":"Jeon SW, Kim YK (2016) Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? World J Psychiatry 6(3):283\u2013293. https:\/\/doi.org\/10.5498\/wjp.v6.i3.283","journal-title":"World J Psychiatry"},{"issue":"7","key":"3563_CR153","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.psyneuen.2012.11.004","volume":"38","author":"M Girotti","year":"2013","unstructured":"Girotti M, Donegan JJ, Morilak DA (2013) Influence of hypothalamic IL-6\/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology 38(7):1158\u20131169. https:\/\/doi.org\/10.1016\/j.psyneuen.2012.11.004","journal-title":"Psychoneuroendocrinology"},{"key":"3563_CR154","doi-asserted-by":"publisher","unstructured":"Ting EY, Yang AC, Tsai SJ (2020) Role of interleukin-6 in depressive disorder. Int J Mol Sci 21(6). https:\/\/doi.org\/10.3390\/ijms21062194","DOI":"10.3390\/ijms21062194"},{"issue":"6","key":"3563_CR155","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/s1734-1140(13)71526-3","volume":"65","author":"G Anderson","year":"2013","unstructured":"Anderson G, Kubera M, Duda W, Laso\u0144 W, Berk M, Maes M (2013) Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression. Pharmacol Rep 65(6):1647\u20131654. https:\/\/doi.org\/10.1016\/s1734-1140(13)71526-3","journal-title":"Pharmacol Rep"},{"issue":"1","key":"3563_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/neu.2016.69","volume":"30","author":"BE Leonard","year":"2018","unstructured":"Leonard BE (2018) Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr 30(1):1\u201316. https:\/\/doi.org\/10.1017\/neu.2016.69","journal-title":"Acta Neuropsychiatr"},{"issue":"5","key":"3563_CR157","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","volume":"56","author":"B Lima Giacobbo","year":"2019","unstructured":"Lima Giacobbo B, Doorduin J, Klein HC, Dierckx R, Bromberg E, de Vries EFJ (2019) Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol Neurobiol 56(5):3295\u20133312. https:\/\/doi.org\/10.1007\/s12035-018-1283-6","journal-title":"Mol Neurobiol"},{"issue":"3","key":"3563_CR158","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000506133","volume":"79","author":"JB Belge","year":"2020","unstructured":"Belge JB, van Diermen L, Sabbe B, Parizel P, Morrens M, Coppens V, Constant E, de Timary P, et al (2020) Inflammation, hippocampal volume, and therapeutic outcome following electroconvulsive therapy in depressive patients: a pilot study. Neuropsychobiology 79(3):222\u2013232. https:\/\/doi.org\/10.1159\/000506133","journal-title":"Neuropsychobiology"},{"key":"3563_CR159","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jad.2020.06.068","volume":"276","author":"YL Zhou","year":"2020","unstructured":"Zhou YL, Wu FC, Wang CY, Zheng W, Lan XF, Deng XR, Ning YP (2020) Relationship between hippocampal volume and inflammatory markers following six infusions of ketamine in major depressive disorder. J Affect Disord 276:608\u2013615. https:\/\/doi.org\/10.1016\/j.jad.2020.06.068","journal-title":"J Affect Disord"},{"issue":"4","key":"3563_CR160","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.neuroimage.2010.11.011","volume":"54","author":"G Salvadore","year":"2011","unstructured":"Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, Cannon DM, Neumeister A, Zarate CA Jr, et al (2011) Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage 54(4):2643\u20132651. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.11.011","journal-title":"Neuroimage"},{"issue":"11","key":"3563_CR161","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/hbm.20801","volume":"30","author":"PC Koolschijn","year":"2009","unstructured":"Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS (2009) Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 30(11):3719\u20133735. https:\/\/doi.org\/10.1002\/hbm.20801","journal-title":"Hum Brain Mapp"},{"issue":"6","key":"3563_CR162","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1176\/appi.ajp.158.6.899","volume":"158","author":"SH Kennedy","year":"2001","unstructured":"Kennedy SH, Evans KR, Kr\u00fcger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ (2001) Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 158(6):899\u2013905. https:\/\/doi.org\/10.1176\/appi.ajp.158.6.899","journal-title":"Am J Psychiatry"},{"issue":"1","key":"3563_CR163","doi-asserted-by":"publisher","first-page":"10054","DOI":"10.1038\/s41598-018-28300-5","volume":"8","author":"S Kakeda","year":"2018","unstructured":"Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Igata N, Ueda I, Igata R, Abe O, Yoshimura R, Korogi Y (2018) Relationship between interleukin (IL)-6 and brain morphology in drug-na\u00efve, first-episode major depressive disorder using surface-based morphometry. Sci Rep 8(1):10054. https:\/\/doi.org\/10.1038\/s41598-018-28300-5","journal-title":"Sci Rep"},{"issue":"5","key":"3563_CR164","doi-asserted-by":"publisher","first-page":"e1138","DOI":"10.1038\/tp.2017.112","volume":"7","author":"JC Zhang","year":"2017","unstructured":"Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Hashimoto K (2017) Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis. Transl Psychiatry 7(5):e1138. https:\/\/doi.org\/10.1038\/tp.2017.112","journal-title":"Transl Psychiatry"},{"issue":"9","key":"3563_CR165","doi-asserted-by":"publisher","first-page":"e025333","DOI":"10.1136\/bmjopen-2018-025333","volume":"8","author":"GM Khandaker","year":"2018","unstructured":"Khandaker GM, Oltean BP, Kaser M, Dibben CRM, Ramana R, Jadon DR, Dantzer R, Coles AJ, Lewis G, Jones PB (2018) Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation. BMJ Open 8(9):e025333. https:\/\/doi.org\/10.1136\/bmjopen-2018-025333","journal-title":"BMJ Open"},{"issue":"12","key":"3563_CR166","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.3390\/cimb44120429","volume":"44","author":"MY Zhanina","year":"2022","unstructured":"Zhanina MY, Druzhkova TA, Yakovlev AA, Vladimirova EE, Freiman SV, Eremina NN, Guekht AB, Gulyaeva NV (2022) Development of post-stroke cognitive and depressive disturbances: associations with neurohumoral indices. Curr Issues Mol Biol 44(12):6290\u20136305. https:\/\/doi.org\/10.3390\/cimb44120429","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"3563_CR167","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.18502\/ijph.v50i6.6423","volume":"50","author":"Y Cui","year":"2021","unstructured":"Cui Y, Ma G, Kong F, Song L (2021) Diagnostic values of miR-221-3p in serum and cerebrospinal fluid for post-stroke depression and analysis of risk factors. Iran J Public Health 50(6):1241\u20131249. https:\/\/doi.org\/10.18502\/ijph.v50i6.6423","journal-title":"Iran J Public Health"},{"issue":"11","key":"3563_CR168","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jpsychires.2009.05.010","volume":"43","author":"FS Dhabhar","year":"2009","unstructured":"Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI, Wolkowitz OM (2009) Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res 43(11):962\u2013969. https:\/\/doi.org\/10.1016\/j.jpsychires.2009.05.010","journal-title":"J Psychiatr Res"},{"key":"3563_CR169","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fpsyt.2017.00250","volume":"8","author":"F Euteneuer","year":"2017","unstructured":"Euteneuer F, Dannehl K, Del Rey A, Engler H, Schedlowski M, Rief W (2017) Peripheral immune alterations in major depression: the role of subtypes and pathogenetic characteristics. Front Psychiatry 8:250. https:\/\/doi.org\/10.3389\/fpsyt.2017.00250","journal-title":"Front Psychiatry"},{"key":"3563_CR170","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.psychres.2019.01.100","volume":"273","author":"CD Wiener","year":"2019","unstructured":"Wiener CD, Moreira FP, Portela LV, Strogulski NR, Lara DR, da Silva RA, Souza LDM, Jansen K, Oses JP (2019) Interleukin-6 and interleukin-10 in mood disorders: a population-based study. Psychiatry Res 273:685\u2013689. https:\/\/doi.org\/10.1016\/j.psychres.2019.01.100","journal-title":"Psychiatry Res"},{"key":"3563_CR171","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.eurpsy.2018.10.001","volume":"57","author":"SZ Al-Fadhel","year":"2019","unstructured":"Al-Fadhel SZ, Al-Hakeim HK, Al-Dujaili AH, Maes M (2019) IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder. Eur Psychiatry 57:46\u201351. https:\/\/doi.org\/10.1016\/j.eurpsy.2018.10.001","journal-title":"Eur Psychiatry"},{"issue":"13","key":"3563_CR172","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1038\/s41386-018-0154-1","volume":"43","author":"G Laumet","year":"2018","unstructured":"Laumet G, Edralin JD, Chiang AC, Dantzer R, Heijnen CJ, Kavelaars A (2018) Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling. Neuropsychopharmacology 43(13):2597\u20132605. https:\/\/doi.org\/10.1038\/s41386-018-0154-1","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"3563_CR173","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12974-020-01871-9","volume":"17","author":"HY Zhang","year":"2020","unstructured":"Zhang HY, Wang Y, He Y, Wang T, Huang XH, Zhao CM, Zhang L, Li SW, Wang C, Qu YN, Jiang XX (2020) A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment. J Neuroinflammation 17(1):200. https:\/\/doi.org\/10.1186\/s12974-020-01871-9","journal-title":"J Neuroinflammation"},{"key":"3563_CR174","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jad.2022.06.043","volume":"314","author":"M Langhein","year":"2022","unstructured":"Langhein M, Seitz-Holland J, Lyall AE, Pasternak O, Chunga N, Cetin-Karayumak S, Kubicki A, Mulert C, Espinoza RT, Narr KL, Kubicki M (2022) Association between peripheral inflammation and free-water imaging in major depressive disorder before and after ketamine treatment - a pilot study. J Affect Disord 314:78\u201385. https:\/\/doi.org\/10.1016\/j.jad.2022.06.043","journal-title":"J Affect Disord"},{"issue":"6","key":"3563_CR175","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/glia.22647","volume":"62","author":"DM Norden","year":"2014","unstructured":"Norden DM, Fenn AM, Dugan A, Godbout JP (2014) TGF\u03b2 produced by IL-10 redirected astrocytes attenuates microglial activation. Glia 62(6):881\u2013895. https:\/\/doi.org\/10.1002\/glia.22647","journal-title":"Glia"},{"issue":"11","key":"3563_CR176","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3109\/00207454.2012.709892","volume":"122","author":"H Ormstad","year":"2012","unstructured":"Ormstad H, Aass HC, Amthor KF, Lund-S\u00f8rensen N, Sandvik L (2012) Serum levels of cytokines, glucose, and hemoglobin as possible predictors of poststroke depression, and association with poststroke fatigue. Int J Neurosci 122(11):682\u2013690. https:\/\/doi.org\/10.3109\/00207454.2012.709892","journal-title":"Int J Neurosci"},{"key":"3563_CR177","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jad.2015.04.044","volume":"182","author":"HK Al-Hakeim","year":"2015","unstructured":"Al-Hakeim HK, Al-Rammahi DA, Al-Dujaili AH (2015) IL-6, IL-18, sIL-2R, and TNF\u03b1 proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J Affect Disord 182:106\u2013114. https:\/\/doi.org\/10.1016\/j.jad.2015.04.044","journal-title":"J Affect Disord"},{"key":"3563_CR178","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-2094-10-43","volume":"10","author":"S Najjar","year":"2013","unstructured":"Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O (2013) Neuroinflammation and psychiatric illness. J Neuroinflammation 10:43. https:\/\/doi.org\/10.1186\/1742-2094-10-43","journal-title":"J Neuroinflammation"},{"issue":"10","key":"3563_CR179","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","volume":"38","author":"R Yirmiya","year":"2015","unstructured":"Yirmiya R, Rimmerman N, Reshef R (2015) Depression as a microglial disease. Trends Neurosci 38(10):637\u2013658. https:\/\/doi.org\/10.1016\/j.tins.2015.08.001","journal-title":"Trends Neurosci"},{"key":"3563_CR180","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2013.10.017","volume":"36","author":"E Alcocer-G\u00f3mez","year":"2014","unstructured":"Alcocer-G\u00f3mez E, de Miguel M, Casas-Barquero N, N\u00fa\u00f1ez-Vasco J, S\u00e1nchez-Alcazar JA, Fern\u00e1ndez-Rodr\u00edguez A, Cordero MD (2014) NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun 36:111\u2013117. https:\/\/doi.org\/10.1016\/j.bbi.2013.10.017","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3563_CR181","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainresrev.2007.11.003","volume":"58","author":"S Sugama","year":"2008","unstructured":"Sugama S, Conti B (2008) Interleukin-18 and stress. Brain Res Rev 58(1):85\u201395. https:\/\/doi.org\/10.1016\/j.brainresrev.2007.11.003","journal-title":"Brain Res Rev"},{"issue":"4","key":"3563_CR182","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1210\/edrv.20.4.0375","volume":"20","author":"LI McKay","year":"1999","unstructured":"McKay LI, Cidlowski JA (1999) Molecular control of immune\/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 20(4):435\u2013459. https:\/\/doi.org\/10.1210\/edrv.20.4.0375","journal-title":"Endocr Rev"},{"issue":"9","key":"3563_CR183","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","volume":"31","author":"CM Pariante","year":"2008","unstructured":"Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31(9):464\u2013468. https:\/\/doi.org\/10.1016\/j.tins.2008.06.006","journal-title":"Trends Neurosci"},{"key":"3563_CR184","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neuroscience.2019.04.003","volume":"408","author":"K Yamanishi","year":"2019","unstructured":"Yamanishi K, Doe N, Mukai K, Ikubo K, Hashimoto T, Uwa N, Sumida M, El-Darawish Y, Gamachi N, et al (2019) Interleukin-18-deficient mice develop hippocampal abnormalities related to possible depressive-like behaviors. Neuroscience 408:147\u2013160. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.04.003","journal-title":"Neuroscience"},{"key":"3563_CR185","doi-asserted-by":"publisher","unstructured":"Fan N, Luo Y, Ou Y, He H (2017) Altered serum levels of TNF-\u03b1, IL-6, and IL-18 in depressive disorder patients. Hum Psychopharmacol 32(4). https:\/\/doi.org\/10.1002\/hup.2588","DOI":"10.1002\/hup.2588"},{"issue":"11","key":"3563_CR186","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/sj.mp.4001879","volume":"11","author":"G Spalletta","year":"2006","unstructured":"Spalletta G, Boss\u00f9 P, Ciaramella A, Bria P, Caltagirone C, Robinson RG (2006) The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 11(11):984\u2013991. https:\/\/doi.org\/10.1038\/sj.mp.4001879","journal-title":"Mol Psychiatry"},{"issue":"12","key":"3563_CR187","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2174\/1570159x18666200620230321","volume":"18","author":"Y Huang","year":"2020","unstructured":"Huang Y, Chen S, Luo Y, Han Z (2020) Crosstalk between Inflammation and the BBB in stroke. Curr Neuropharmacol 18(12):1227\u20131236. https:\/\/doi.org\/10.2174\/1570159x18666200620230321","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"3563_CR188","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s10571-021-01153-9","volume":"42","author":"S Wu","year":"2022","unstructured":"Wu S, Yin Y, Du L (2022) Blood-brain barrier dysfunction in the pathogenesis of major depressive disorder. Cell Mol Neurobiol 42(8):2571\u20132591. https:\/\/doi.org\/10.1007\/s10571-021-01153-9","journal-title":"Cell Mol Neurobiol"},{"key":"3563_CR189","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fncel.2018.00306","volume":"12","author":"L Zhang","year":"2018","unstructured":"Zhang L, Zhang J, You Z (2018) Switching of the microglial activation phenotype is a possible treatment for depression disorder. Front Cell Neurosci 12:306. https:\/\/doi.org\/10.3389\/fncel.2018.00306","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"3563_CR190","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12974-022-02492-0","volume":"19","author":"H Wang","year":"2022","unstructured":"Wang H, He Y, Sun Z, Ren S, Liu M, Wang G, Yang J (2022) Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflammation 19(1):132. https:\/\/doi.org\/10.1186\/s12974-022-02492-0","journal-title":"J Neuroinflammation"},{"key":"3563_CR191","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbi.2017.03.002","volume":"64","author":"FN Kaufmann","year":"2017","unstructured":"Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, Rodrigues ALS, Peluffo H, Kaster MP (2017) NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun 64:367\u2013383. https:\/\/doi.org\/10.1016\/j.bbi.2017.03.002","journal-title":"Brain Behav Immun"},{"key":"3563_CR192","doi-asserted-by":"publisher","first-page":"146777","DOI":"10.1016\/j.brainres.2020.146777","volume":"1736","author":"C Li","year":"2020","unstructured":"Li C, Xu X, Wang Z, Wang Y, Luo L, Cheng J, Chen SF, Liu H, Wan Q, Wang Q (2020) Exercise ameliorates post-stroke depression by inhibiting PTEN elevation-mediated upregulation of TLR4\/NF-\u03baB\/NLRP3 signaling in mice. Brain Res 1736:146777. https:\/\/doi.org\/10.1016\/j.brainres.2020.146777","journal-title":"Brain Res"},{"issue":"4","key":"3563_CR193","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/da.22084","volume":"30","author":"AH Miller","year":"2013","unstructured":"Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30(4):297\u2013306. https:\/\/doi.org\/10.1002\/da.22084","journal-title":"Depress Anxiety"},{"issue":"5\u20136","key":"3563_CR194","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/s0306-9877(03)00207-x","volume":"61","author":"AM Myint","year":"2003","unstructured":"Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61(5\u20136):519\u2013525. https:\/\/doi.org\/10.1016\/s0306-9877(03)00207-x","journal-title":"Med Hypotheses"},{"key":"3563_CR195","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","volume":"45","author":"M Hamon","year":"2013","unstructured":"Hamon M, Blier P (2013) Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry 45:54\u201363. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.04.009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3563_CR196","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbr.2017.04.020","volume":"329","author":"YK Kim","year":"2017","unstructured":"Kim YK, Won E (2017) The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder. Behav Brain Res 329:6\u201311. https:\/\/doi.org\/10.1016\/j.bbr.2017.04.020","journal-title":"Behav Brain Res"},{"key":"3563_CR197","doi-asserted-by":"publisher","first-page":"1125634","DOI":"10.3389\/fimmu.2023.1125634","volume":"14","author":"H Chen","year":"2023","unstructured":"Chen H, Huang X, Zeng C, Sun D, Liu F, Zhang J, Liao Q, Luo S, et al (2023) The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression. Front Immunol 14:1125634. https:\/\/doi.org\/10.3389\/fimmu.2023.1125634","journal-title":"Front Immunol"},{"key":"3563_CR198","doi-asserted-by":"publisher","first-page":"132931","DOI":"10.1016\/j.neulet.2017.06.050","volume":"710","author":"J van Horssen","year":"2019","unstructured":"van Horssen J, van Schaik P, Witte M (2019) Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders? Neurosci Lett 710:132931. https:\/\/doi.org\/10.1016\/j.neulet.2017.06.050","journal-title":"Neurosci Lett"},{"issue":"12","key":"3563_CR199","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1167\/iovs.07-1032","volume":"49","author":"SF Abcouwer","year":"2008","unstructured":"Abcouwer SF, Shanmugam S, Gomez PF, Shushanov S, Barber AJ, Lanoue KF, Quinn PG, Kester M, Gardner TW (2008) Effect of IL-1beta on survival and energy metabolism of R28 and RGC-5 retinal neurons. Invest Ophthalmol Vis Sci 49(12):5581\u20135592. https:\/\/doi.org\/10.1167\/iovs.07-1032","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3563_CR200","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/0929867321666141106122319","volume":"22","author":"SF Nabavi","year":"2015","unstructured":"Nabavi SF, Dean OM, Turner A, Sureda A, Daglia M, Nabavi SM (2015) Oxidative stress and post-stroke depression: possible therapeutic role of polyphenols? Curr Med Chem 22(3):343\u2013351","journal-title":"Curr Med Chem"},{"issue":"3","key":"3563_CR201","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1176\/appi.ajp.2015.15030363","volume":"173","author":"RG Robinson","year":"2016","unstructured":"Robinson RG, Jorge RE (2016) Post-stroke depression: a review. Am J Psychiatry 173(3):221\u2013231. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15030363","journal-title":"Am J Psychiatry"},{"issue":"11","key":"3563_CR202","doi-asserted-by":"publisher","first-page":"Cd009286","DOI":"10.1002\/14651858.CD009286.pub4","volume":"11","author":"LA Legg","year":"2021","unstructured":"Legg LA, Rudberg AS, Hua X, Wu S, Hackett ML, Tilney R, Lindgren L, Kutlubaev MA, et al (2021) Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev 11(11):Cd009286. https:\/\/doi.org\/10.1002\/14651858.CD009286.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"3563_CR203","doi-asserted-by":"publisher","unstructured":"Legg LA, Tilney R, Hsieh CF, Wu S, Lundstr\u00f6m E, Rudberg AS, Kutlubaev MA, Dennis M, et al (2019) Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev 2019(11). https:\/\/doi.org\/10.1002\/14651858.CD009286.pub3","DOI":"10.1002\/14651858.CD009286.pub3"},{"key":"3563_CR204","doi-asserted-by":"publisher","unstructured":"Fang M, Zhong L, Jin X, Cui R, Yang W, Gao S, Lv J, Li B, et al (2019) Effect of inflammation on the process of stroke rehabilitation and poststroke depression. Front Psych 10. https:\/\/doi.org\/10.3389\/fpsyt.2019.00184","DOI":"10.3389\/fpsyt.2019.00184"},{"issue":"2","key":"3563_CR205","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","volume":"23","author":"N Kappelmann","year":"2018","unstructured":"Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM (2018) Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry 23(2):335\u2013343. https:\/\/doi.org\/10.1038\/mp.2016.167","journal-title":"Mol Psychiatry"},{"issue":"9","key":"3563_CR206","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.biopsych.2005.10.013","volume":"59","author":"BB Simen","year":"2006","unstructured":"Simen BB, Duman CH, Simen AA, Duman RS (2006) TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 59(9):775\u2013785. https:\/\/doi.org\/10.1016\/j.biopsych.2005.10.013","journal-title":"Biol Psychiatry"},{"key":"3563_CR207","doi-asserted-by":"publisher","unstructured":"Uzzan S, Azab AN (2021) Anti-TNF-\u03b1 compounds as a treatment for depression. Molecules 26(8). https:\/\/doi.org\/10.3390\/molecules26082368","DOI":"10.3390\/molecules26082368"},{"issue":"9","key":"3563_CR208","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.autrev.2015.05.001","volume":"14","author":"PL Meroni","year":"2015","unstructured":"Meroni PL, Valentini G, Ayala F, Cattaneo A, Valesini G (2015) New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: a systematic analysis. Autoimmun Rev 14(9):812\u2013829. https:\/\/doi.org\/10.1016\/j.autrev.2015.05.001","journal-title":"Autoimmun Rev"},{"key":"3563_CR209","doi-asserted-by":"publisher","unstructured":"Ma K, Zhang H, Baloch Z (2016) Pathogenetic and therapeutic applications of tumor necrosis factor-\u03b1 (TNF-\u03b1) in major depressive disorder: a systematic review. Int J Mol Sci 17(5). https:\/\/doi.org\/10.3390\/ijms17050733","DOI":"10.3390\/ijms17050733"},{"issue":"1","key":"3563_CR210","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat 70(1):31\u201341. https:\/\/doi.org\/10.1001\/2013.jamapsychiatry.4","journal-title":"JAMA Psychiat"},{"issue":"13","key":"3563_CR211","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1523\/jneurosci.5032-08.2009","volume":"29","author":"JC O'Connor","year":"2009","unstructured":"O\u2019Connor JC, Andr\u00e9 C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29(13):4200\u20134209. https:\/\/doi.org\/10.1523\/jneurosci.5032-08.2009","journal-title":"J Neurosci"},{"key":"3563_CR212","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbi.2017.06.014","volume":"66","author":"Y Sun","year":"2017","unstructured":"Sun Y, Wang D, Salvadore G, Hsu B, Curran M, Casper C, Vermeulen J, Kent JM, Singh J, Drevets WC, Wittenberg GM, Chen G (2017) The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman\u2019s disease. Brain Behav Immun 66:156\u2013164. https:\/\/doi.org\/10.1016\/j.bbi.2017.06.014","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3563_CR213","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12974-020-01922-1","volume":"17","author":"RJ Worthen","year":"2020","unstructured":"Worthen RJ, Garzon Zighelboim SS, Torres Jaramillo CS, Beurel E (2020) Anti-inflammatory IL-10 administration rescues depression-associated learning and memory deficits in mice. J Neuroinflammation 17(1):246. https:\/\/doi.org\/10.1186\/s12974-020-01922-1","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3563_CR214","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s1074-7613(00)80013-8","volume":"10","author":"D Novick","year":"1999","unstructured":"Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M (1999) Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10(1):127\u2013136. https:\/\/doi.org\/10.1016\/s1074-7613(00)80013-8","journal-title":"Immunity"},{"issue":"4","key":"3563_CR215","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/01616412.2018.1558000","volume":"41","author":"N Schultz","year":"2019","unstructured":"Schultz N, Hasseldam H, Rasmussen RS, Vindegaard N, McWilliam O, Iversen HK, Johansen FF (2019) Statin treatment before stroke reduces pro-inflammatory cytokine levels after stroke. Neurol Res 41(4):289\u2013297. https:\/\/doi.org\/10.1080\/01616412.2018.1558000","journal-title":"Neurol Res"},{"key":"3563_CR216","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12974-015-0264-1","volume":"12","author":"Z Jin","year":"2015","unstructured":"Jin Z, Liang J, Wang J, Kolattukudy PE (2015) MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia\/reperfusion injury in vitro and in vivo. J Neuroinflammation 12:39. https:\/\/doi.org\/10.1186\/s12974-015-0264-1","journal-title":"J Neuroinflammation"},{"key":"3563_CR217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2019.11.009","volume":"155","author":"QM Camargos","year":"2020","unstructured":"Camargos QM, Silva BC, Silva DG, Toscano ECB, Oliveira BDS, Bellozi PMQ, Jardim BLO, Vieira \u00c9LM, et al (2020) Minocycline treatment prevents depression and anxiety-like behaviors and promotes neuroprotection after experimental ischemic stroke. Brain Res Bull 155:1\u201310. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.11.009","journal-title":"Brain Res Bull"},{"key":"3563_CR218","doi-asserted-by":"publisher","unstructured":"La Russa D, Di Santo C, Lizasoain I, Moraga A, Bagetta G, Amantea D (2023) Tumor necrosis factor (TNF)-\u03b1-stimulated gene 6 (TSG-6): a promising immunomodulatory target in acute neurodegenerative diseases. Int J Mol Sci 24(2). https:\/\/doi.org\/10.3390\/ijms24021162","DOI":"10.3390\/ijms24021162"},{"issue":"6","key":"3563_CR219","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/strokeaha.111.000504","volume":"44","author":"H Zhao","year":"2013","unstructured":"Zhao H, Wang J, Gao L, Wang R, Liu X, Gao Z, Tao Z, Xu C, et al (2013) MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke 44(6):1706\u20131713. https:\/\/doi.org\/10.1161\/strokeaha.111.000504","journal-title":"Stroke"},{"issue":"6","key":"3563_CR220","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1111\/jnc.15222","volume":"157","author":"WJ Suento","year":"2021","unstructured":"Suento WJ, Kunisawa K, Wulaer B, Kosuge A, Iida T, Fujigaki S, Fujigaki H, Yamamoto Y, et al (2021) Prefrontal cortex miR-874-3p prevents lipopolysaccharide-induced depression-like behavior through inhibition of indoleamine 2,3-dioxygenase 1 expression in mice. J Neurochem 157(6):1963\u20131978. https:\/\/doi.org\/10.1111\/jnc.15222","journal-title":"J Neurochem"},{"issue":"6","key":"3563_CR221","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00213-021-05783-1","volume":"238","author":"A Partoazar","year":"2021","unstructured":"Partoazar A, Seyyedian Z, Zamanian G, Saffari PM, Muhammadnejad A, Dehpour AR, Goudarzi R (2021) Neuroprotective phosphatidylserine liposomes alleviate depressive-like behavior related to stroke through neuroinflammation attenuation in the mouse hippocampus. Psychopharmacology 238(6):1531\u20131539. https:\/\/doi.org\/10.1007\/s00213-021-05783-1","journal-title":"Psychopharmacology"},{"key":"3563_CR222","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12974-014-0232-1","volume":"12","author":"HL Walter","year":"2015","unstructured":"Walter HL, van der Maten G, Antunes AR, Wieloch T, Ruscher K (2015) Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke. J Neuroinflammation 12:24. https:\/\/doi.org\/10.1186\/s12974-014-0232-1","journal-title":"J Neuroinflammation"},{"key":"3563_CR223","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuint.2017.03.017","volume":"111","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Lee JH, Chen D, Gu X, Caslin A, Li J, Yu SP, Wei L (2017) DL-3-n-butylphthalide induced neuroprotection, regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice. Neurochem Int 111:82\u201392. https:\/\/doi.org\/10.1016\/j.neuint.2017.03.017","journal-title":"Neurochem Int"},{"key":"3563_CR224","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbrc.2021.03.104","volume":"554","author":"Q Yin","year":"2021","unstructured":"Yin Q, Du T, Yang C, Li X, Zhao Z, Liu R, Yang B, Liu B (2021) Gadd45b is a novel mediator of depression-like behaviors and neuroinflammation after cerebral ischemia. Biochem Biophys Res Commun 554:107\u2013113. https:\/\/doi.org\/10.1016\/j.bbrc.2021.03.104","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"3563_CR225","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1017\/s1041610219002187","volume":"32","author":"R Perrain","year":"2020","unstructured":"Perrain R, Mekaoui L, Calvet D, Mas JL, Gorwood P (2020) A meta-analysis of poststroke depression risk factors comparing depressive-related factors versus others. Int Psychogeriatr 32(11):1331\u20131344. https:\/\/doi.org\/10.1017\/s1041610219002187","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"3563_CR226","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1503\/jpn.180015","volume":"43","author":"PR Albert","year":"2018","unstructured":"Albert PR (2018) Is poststroke depression the same as major depression? J Psychiatry Neurosci 43(2):76\u201378. https:\/\/doi.org\/10.1503\/jpn.180015","journal-title":"J Psychiatry Neurosci"},{"key":"3563_CR227","doi-asserted-by":"publisher","first-page":"459692","DOI":"10.1155\/2013\/459692","volume":"2013","author":"H Yan","year":"2013","unstructured":"Yan H, Fang M, Liu XY (2013) Role of microRNAs in stroke and poststroke depression. ScientificWorldJournal 2013:459692. https:\/\/doi.org\/10.1155\/2013\/459692","journal-title":"ScientificWorldJournal"},{"key":"3563_CR228","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jpsychires.2019.05.018","volume":"115","author":"HB Liang","year":"2019","unstructured":"Liang HB, He JR, Tu XQ, Ding KQ, Yang GY, Zhang Y, Zeng LL (2019) MicroRNA-140-5p: A novel circulating biomarker for early warning of late-onset post-stroke depression. J Psychiatr Res 115:129\u2013141. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.05.018","journal-title":"J Psychiatr Res"},{"key":"3563_CR229","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbi.2019.01.003","volume":"78","author":"A Panta","year":"2019","unstructured":"Panta A, Pandey S, Duncan IN, Duhamel S, Sohrabji F (2019) Mir363-3p attenuates post-stroke depressive-like behaviors in middle-aged female rats. Brain Behav Immun 78:31\u201340. https:\/\/doi.org\/10.1016\/j.bbi.2019.01.003","journal-title":"Brain Behav Immun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03563-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03563-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03563-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:27:35Z","timestamp":1705379255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03563-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":229,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03563-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}